Taken together, these data point out the possibility that inflammation or metabolic system are the key elements of action of MCH and OX systems [25, 61–63] in the pathophysiology of ischemic stroke as well as in the beneficial effect of SD intervention. This evidence concerns the gene PMCH and ischemic stroke.